拉米夫定对肺结核并HBV感染患者的作用及意义(3)

http://www.100md.com 2009年7月25日 徐　风　王正春　王燕华　彭　毅　王　烽　郑　军　罗菊珍　肖木

第1页

    参见附件(2076KB，3页)。

     [参考文献]

    [1]何国均.抗结核化疗的进展和存在在问题浅议[J].中华结核和呼吸杂志,1993,16(2):67.

    [2]Doong SL, Tsai CH, Scninazi RF, et al. Inhibitiom of the replication of hepatitis B virus in vitro by 2’ 3’-dideoxy-3’-thiacytidine and related analoyues[J]. Proc Natl Acad Sci USA,1991,88:8495-8499.

    [3]Tyneil DLJ ,Fischer K, Sayani K. et al. Treatment Of chimpanzees and ducks with Lamivudine 2’-3’-dideoxg-3’-thiacytidine results in a repid suppression of hepadnaviral DNA in sera[J].Clin Invest Med,1993,16(suppl):877.

    [4]Lai CL, Ching CK, TungAKM, et al. Lamivudine is effective in suppressing hepatitis B Virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial[J].Hepatology,1997,25:241-244.

    [5]Lai CL. Chien RN, Leung NWY, et al. One-year trial a Lamivudine for chronic hepatitis B[J].N Eng J Med,1998,339:61-68.

    [6]徐风,陈惠兰,严斌,等.肺结核合并HBV感染患者血清HBV-DNA的检测及其意义[J].中华结核和呼吸杂志,1995,18(4):10.

    [7]Singleton JW, Merrill DA, Fitch RA ,et al. Liver disease in Australia antigen-positive blood donorso[J].Lancet,1971,2:785.

    [8]Simon JB, Patel SK. Liver disease in asymptomatic carriers of hepatitis B antigen[J].Gastroentcrology,1974,66:1020.

    [9]Samptiner R. Chronic active hepatitis in hepatitis B surface antigen carriers[J].JAMA,1997,237:50.

    [10]黄孝桂,张钢.抗结核过程中肝功能异常的分析(附25例肝治检病理资料)[J].中国防痨杂志,1992,14(4):155.

    [11]韩素霖,蔡斌.抗结核药物对乙肝病毒标志物阳性者肝功能的影响[J].中国防痨杂志,1994,16(2):63.

    (收稿日期:2009-06-10)

    http://www.100md.com/html/paper/1673-0089/2009/21/42-2.htm

您现在查看是摘要介绍页，详见PDF附件(2076KB，3页)。